{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:53:48Z","timestamp":1784328828599,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","award":["140008186871"],"award-info":[{"award-number":["140008186871"]}],"id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins & Other Lipid Mediators"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.prostaglandins.2025.106969","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T16:16:58Z","timestamp":1740586618000},"page":"106969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The interplay of LDLR, PCSK9, and lncRNA- LASER genes expression in coronary artery disease: Implications for therapeutic interventions"],"prefix":"10.1016","volume":"177","author":[{"given":"Tayebe","family":"Ghiasvand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Khodadadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Khazaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra Abedi","family":"kichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Kianoosh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.prostaglandins.2025.106969_bib1","first-page":"2982","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Gam","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.prostaglandins.2025.106969_bib2","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk: a compass for future health","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.prostaglandins.2025.106969_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1018460","article-title":"Association between sedentary behavior, physical activity, and cardiovascular disease-related outcomes in adults\u2014A meta-analysis and systematic review","volume":"10","author":"Liang","year":"2022","journal-title":"Front. Public Health"},{"issue":"4","key":"10.1016\/j.prostaglandins.2025.106969_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.31083\/j.rcm2304135","article-title":"Aging and cardiovascular disease: current status and challenges","volume":"23","author":"Zhou","year":"2022","journal-title":"Rev. Cardiovasc. Med."},{"issue":"5","key":"10.1016\/j.prostaglandins.2025.106969_bib5","first-page":"203","article-title":"Coronary artery disease","volume":"2","author":"Beki","year":"2023","journal-title":"Eurasia J. Chem. Med. Pet. Res."},{"key":"10.1016\/j.prostaglandins.2025.106969_bib6","series-title":"Coronary Artery Disease","author":"Shahjehan","year":"2023"},{"key":"10.1016\/j.prostaglandins.2025.106969_bib7","article-title":"Klotho, FOXO1 and cytokines associations in patients with coronary artery disease","volume":"141","author":"Fard","year":"2021","journal-title":"Cytokine"},{"issue":"_1","key":"10.1016\/j.prostaglandins.2025.106969_bib8","first-page":"A453","article-title":"Sestrin1 is required to maintain plasma cholesterol homeostasis during cholesterol feeding","volume":"38","author":"Li","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2025.106969_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101658","article-title":"Approach to patients with elevated low-density lipoprotein cholesterol levels","volume":"37","author":"Feingold","year":"2023","journal-title":"Best. Pract. Res Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.prostaglandins.2025.106969_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7150\/ijbs.14027","article-title":"Dysregulation of the low-density lipoprotein receptor pathway is involved in lipid disorder-mediated organ injury","volume":"12","author":"Zhang","year":"2016","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.prostaglandins.2025.106969_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MOL.0000000000000411","article-title":"News on the molecular regulation and function of hepatic LDLR and LRP1","volume":"28","author":"Van De Sluis","year":"2017","journal-title":"Curr. Opin. Lipido"},{"key":"10.1016\/j.prostaglandins.2025.106969_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102650","article-title":"A small-molecule inhibitor of PCSK9 transcription ameliorates atherosclerosis through the modulation of FoxO1\/3 and HNF1\u03b1","volume":"52","author":"Wang","year":"2020","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.prostaglandins.2025.106969_bib13","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation","volume":"100","author":"Seidah","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.prostaglandins.2025.106969_bib14","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3390\/ijms24031966","article-title":"PCSK9 as an atherothrombotic risk factor","volume":"24","author":"Sotler","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.prostaglandins.2025.106969_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13459","article-title":"PCSK9 and atherosclerosis: looking beyond LDL regulation","volume":"51","author":"Ragusa","year":"2021","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.prostaglandins.2025.106969_bib16","article-title":"Effect of PCSK9 on atherosclerotic cardiovascular diseases and its mechanisms: focus on immune regulation","volume":"10","author":"Ma","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"9","key":"10.1016\/j.prostaglandins.2025.106969_bib17","first-page":"483","article-title":"The PCSK9 inhibitors: a novel therapeutic target enters clinical practice","volume":"8","author":"Lepor","year":"2015","journal-title":"Am. Health Drug Benefits"},{"issue":"12","key":"10.1016\/j.prostaglandins.2025.106969_bib18","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1105803","article-title":"Effect of a monoclonal antibody to PCSK9 on LDL cholesterol","volume":"366","author":"Stein","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.prostaglandins.2025.106969_bib19","doi-asserted-by":"crossref","first-page":"8337","DOI":"10.3390\/ijms21218337","article-title":"Long non-coding RNA associated with cholesterol homeostasis and its involvement in metabolic diseases","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.prostaglandins.2025.106969_bib20","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3390\/biomedicines11030742","article-title":"Cholesterol-related lncRNAs as response predictors of atorvastatin treatment in chilean hypercholesterolemic patients: a pilot study","volume":"11","author":"Paez","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.prostaglandins.2025.106969_bib21","article-title":"LncRNAs as therapeutic targets and potential biomarkers for lipid-related diseases","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106969_bib22","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.1038\/s41598-019-44195-2","article-title":"Regulation of cholesterol homeostasis by a novel long non-coding RNA LASER","volume":"9","author":"Li","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.prostaglandins.2025.106969_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/ph15020151","article-title":"Beyond lipid-lowering: effects of statins on cardiovascular and cerebrovascular diseases and cancer","volume":"15","author":"Morofuji","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"43","key":"10.1016\/j.prostaglandins.2025.106969_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012813","article-title":"Association of lymphocyte to monocyte ratio with severity of coronary artery disease","volume":"97","author":"Gong","year":"2018","journal-title":"Medicine"},{"issue":"41","key":"10.1016\/j.prostaglandins.2025.106969_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027331","article-title":"Using the Gensini score to estimate severity of STEMI, NSTEMI, unstable angina, and anginal syndrome","volume":"100","author":"Charach","year":"2021","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106969_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12863-024-01275-1","article-title":"Evaluating SORT1 and SESN1 genes expression in peripheral blood mononuclear cells and oxidative stress status in patients with coronary artery disease","volume":"25","author":"Ghiasvand","year":"2024","journal-title":"BMC Genom. Data"},{"issue":"4","key":"10.1016\/j.prostaglandins.2025.106969_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng.784","article-title":"Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease","volume":"43","author":"Schunkert","year":"2011","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106969_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng.291","article-title":"Common variants at 30 loci contribute to polygenic dyslipidemia","volume":"41","author":"Kathiresan","year":"2009","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.prostaglandins.2025.106969_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.prostaglandins.2025.106969_bib30","unstructured":"R.D. Shahjehan, B.S. BhuttaCoronary artery disease, 2020."},{"issue":"5","key":"10.1016\/j.prostaglandins.2025.106969_bib31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/biom11050623","article-title":"Regulation of long non-coding RNAs by statins in atherosclerosis","volume":"11","author":"Tsilimigras","year":"2021","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.prostaglandins.2025.106969_bib32","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3390\/cells12121648","article-title":"A review of progress on targeting LDL receptor-dependent and-independent pathways for the treatment of hypercholesterolemia, a major risk factor of ASCVD","volume":"12","author":"Srivastava","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106969_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","article-title":"Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics","volume":"7","author":"Duan","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"2","key":"10.1016\/j.prostaglandins.2025.106969_bib34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI116663","article-title":"Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery","volume":"92","author":"Ishibashi","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.prostaglandins.2025.106969_bib35","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/nm.3949","article-title":"MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels","volume":"21","author":"Goedeke","year":"2015","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.prostaglandins.2025.106969_bib36","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.atherosclerosis.2013.10.015","article-title":"Dietary phytosterol does not accumulate in the arterial wall and prevents atherosclerosis of LDLr-KO mice","volume":"231","author":"Bombo","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.prostaglandins.2025.106969_bib37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/978-1-0716-1924-7_27","article-title":"Atherosclerosis induced by Adeno-associated virus encoding gain-of-function PCSK9 proprotein convertase subtilisin\/kexin type-9 (PCSK9)","author":"Bj\u00f8rklund","year":"2022","journal-title":"Atheroscler. Methods Protoc."},{"issue":"5","key":"10.1016\/j.prostaglandins.2025.106969_bib38","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.hlc.2015.10.017","article-title":"Plasma proprotein convertase subtilisin kexin type 9 as a predictor of carotid atherosclerosis in asymptomatic adults","volume":"25","author":"Chan","year":"2016","journal-title":"Heart Lung Circ."},{"issue":"9","key":"10.1016\/j.prostaglandins.2025.106969_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106294","article-title":"Plasma PCSK9 levels are elevated with acute myocardial infarction in two independent retrospective angiographic studies","volume":"9","author":"Almontashiri","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.prostaglandins.2025.106969_bib40","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/labinvest.2017.47","article-title":"Accelerated atherosclerosis development in C57Bl6 mice by overexpressing AAV-mediated PCSK9 and partial carotid ligation","volume":"97","author":"Kumar","year":"2017","journal-title":"Lab Invest."},{"issue":"2","key":"10.1016\/j.prostaglandins.2025.106969_bib41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1194\/jlr.M078360","article-title":"PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction","volume":"59","author":"Sun","year":"2018","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106969_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41392-023-01690-3","article-title":"Targeting proprotein convertase subtilisin\/kexin type 9 (PCSK9): from bench to bedside","volume":"9","author":"Bao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.prostaglandins.2025.106969_bib43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jacc.2018.10.039","article-title":"Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial","volume":"73","author":"Szarek","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.prostaglandins.2025.106969_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173114","article-title":"Statins and PCSK9 inhibitors: a new lipid-lowering therapy","volume":"878","author":"Gallego-Colon","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2025.106969_bib45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.atherosclerosis.2019.08.020","article-title":"The Arg499His gain-of-function mutation in the C-terminal domain of PCSK9","volume":"289","author":"S\u00e1nchez-Hern\u00e1ndez","year":"2019","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.prostaglandins.2025.106969_bib46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nsmb1235","article-title":"Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia","volume":"14","author":"Cunningham","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"11","key":"10.1016\/j.prostaglandins.2025.106969_bib47","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI29383","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice","volume":"116","author":"Lagace","year":"2006","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106969_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12864-019-6093-3","article-title":"Long noncoding RNAs in lipid metabolism: literature review and conservation analysis across species","volume":"20","author":"Muret","year":"2019","journal-title":"BMC Genom."},{"key":"10.1016\/j.prostaglandins.2025.106969_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.688546","article-title":"Potential therapeutic targeting of lncRNAs in cholesterol homeostasis","volume":"8","author":"Ye","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"9","key":"10.1016\/j.prostaglandins.2025.106969_bib50","doi-asserted-by":"crossref","first-page":"895","DOI":"10.5551\/jat.RV17012","article-title":"Lipid lowering therapy and circulating PCSK9 concentration","volume":"24","author":"Nozue","year":"2017","journal-title":"J. Atheroscler. Thromb."},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106969_bib51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","article-title":"Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics","volume":"7","author":"Duan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prostaglandins.2025.106969_bib52","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2147\/DMSO.S236915","article-title":"Loss of HNF1\u03b1 function contributes to hepatocyte proliferation and abnormal cholesterol metabolism via downregulating miR-122: a novel mechanism of MODY3","author":"Hu","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."}],"container-title":["Prostaglandins & Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109888232500022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109888232500022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T11:16:59Z","timestamp":1742296619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109888232500022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":52,"alternative-id":["S109888232500022X"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2025.106969","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The interplay of LDLR, PCSK9, and lncRNA- LASER genes expression in coronary artery disease: Implications for therapeutic interventions","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2025.106969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106969"}}